生物源性杀钉螺药物研究进展  

Advances in researches of biogenic molluscicides

作　　者：李雪[1] 戴建荣[1] 邢云天[1] 

机构地区：[1]江苏省血吸虫病防治研究所,国家卫生和计划生育委员会寄生虫病预防与控制技术重点实验室,江苏省寄生虫与媒介控制技术重点实验室,无锡214064

出　　处：《中国血吸虫病防治杂志》2017年第1期122-125,共4页Chinese Journal of Schistosomiasis Control

基　　金：江苏省自然科学基金(SBK2015021308);江苏省无锡市卫生计生重大项目(Z201607)

摘　　要：生物源性杀螺药是指利用植物、动物和微生物或其代谢产物,或者是通过合成具有杀螺活性的仿生药物,对螺类进行控制的一类药物。随着科学技术的迅速发展,生物源性杀螺药新品种不断出现,其范畴亦不断扩大。按照杀螺有效成分和来源分类,目前研究比较深入的生物源性杀螺药主要包括植物源性杀螺药、微生物活菌杀螺药、微生物代谢产物杀螺药及动物源性杀螺药。本文就近年来生物源性杀螺药的研究进展作一综述。Biogenic molluscicides refer to the use of plants, animals and micro-organisms or their metabolites, and synthesis biomimetic molluscicides to kill Oncomelania hupensis snails. With the rapid development of science and technology, new biogenie molluseicides are continuously emerging and the category also continues to expand. According to the molluscicidal active ingredient and sources, at present, the biogenic molluscicides with in-depth studies include plant-derived molluscicides, micro-organism molluscicides, microbial metabolite molluscicides and animal molluscicidcs. This paper reviews the advances in the researches of biogenic molluscicides in recent years.

关 键 词：钉螺 生物源性杀螺药 植物源性杀螺药 微生物活菌杀螺药 微生物代谢产物杀螺药 动物源性杀螺药 

分 类 号：R383.24[医药卫生—医学寄生虫学]